Live Breaking News & Updates on Newton international
Stay updated with breaking news from Newton international. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.S. men posted the greatest loss in life expectancy from COVID-19 japantimes.co.jp - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from japantimes.co.jp Daily Mail and Mail on Sunday newspapers.
Covid Cuts Two Years Off the Life Expectancy of U.S. Men swissinfo.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swissinfo.ch Daily Mail and Mail on Sunday newspapers.
Covid-19 cuts two years off the life expectancy of U.S.... dailymaverick.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymaverick.co.za Daily Mail and Mail on Sunday newspapers.
Mapping child survival and why it matters for the Kenyan child: Insights from geospatial modelling lshtm.ac.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lshtm.ac.uk Daily Mail and Mail on Sunday newspapers.
Application Deadline: June 16th 2021 The Newton International Fellowship are for non-UK scientists who are at an early stage of their research career and wish to conduct research in the UK. The Newton International Fellowship is a flexible award. It can be held on either a full-time or on a part-time basis (minimum 0.6FTE) for caring responsibilities. There is also provision for maternity, paternity, shared parental leave, adoptive or extended sick leave as well as financial support for childcare costs that arise from attending conferences. Successful applicants may also be eligible to receive annual funding following completion of their fellowship to support networking activities with UK-based researchers.
Editorial Article: PARP inhibitors: A new frontier in the battle against cervical cancer Dr. Santu Saha shares his team’s groundbreaking work to develop improved cancer treatments to avoid the potential side effects of chemotherapy 05 Feb 2021 Dr. Santu Saha, Newton International Fellow of the Academy of Medical Sciences, Newcastle University In this exclusive interview, we hear from Dr. Santu Saha about his ongoing research into effective new ways to treat cervical cancer. Dr. Saha, a Newton International fellow of the Academy of Medical Sciences working at Newcastle University, U.K., outlines how a DNA damage response pathway inhibitor, i.e. poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi), can be used to serve as reliable cancer therapies to ameliorate cisplatin toxicity whilst also targeting hypoxic tumor cells for the treatment of cervical and other cancers, where cisplatin-based chemo-radiotherapy is the standard treatment.